An exploratory study to characterise changes in airway inflammation, symptoms, lung function and reliever use in adult asthma patients

Trial Identifier: D589BC00018
Sponsor: AstraZeneca
NCTID:: NCT03924635
Start Date: August 2019
Primary Completion Date: December 2022
Study Completion Date: December 2022
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations